In contrast, LPS treatment increased the mRNA expression of IL19 and IL24, TGF-β1, H2O2 and IL-1β treatment increased that of IL19, and TGF-β1 treatment decreased the mRNA expression of IL20 in CKD-derived PBMCs (Fig. 4d–f). This evidence concerns the gene IL1B and chronic kidney disease.